Dr. Philippe Armand, MD, PhD

Claim this profile

Dana-Farber Cancer Institute

Studies Hodgkin's Lymphoma
Studies Lymphoma
2 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
Dana Farber Cancer Institute

Clinical Trials Philippe Armand, MD, PhD is currently running

Image of trial facility.

Brentuximab Vedotin + Nivolumab

for Hodgkin's Lymphoma

This phase II trial investigates how well brentuximab vedotin and nivolumab work in treating patients with classical Hodgkin lymphoma that has come back after initial treatment (relapsed) or has not responded to initial treatment (refractory). Brentuximab vedotin is a monoclonal antibody, brentuximab, linked to a toxic agent called vedotin. Brentuximab attaches to CD30 positive cancer cells in a targeted way and delivers vedotin to kill them. Nivolumab is an antibody that enhances the immune system to better fight Hodgkin lymphoma cells. Giving brentuximab vedotin and nivolumab may be able to defer stem cell transplant treatment and spare the considerable cost and toxicity on transplantation.
Recruiting1 award Phase 224 criteria

More about Philippe Armand, MD, PhD

Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Philippe Armand, MD, PhD has experience with
  • Brentuximab Vedotin
  • Nivolumab
  • Magrolimab
  • Pembrolizumab
Breakdown of trials Philippe Armand, MD, PhD has run
Hodgkin's Lymphoma
Lymphoma
Cancer

Other Doctors you might be interested in

Sapna Syngal, MDDana Farber Cancer Center, Harvard University
Gregory Cote, MDMassachusetts General Hospital
James M. ClearyDana Farber Cancer Institute

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Philippe Armand, MD, PhD specialize in?
Philippe Armand, MD, PhD focuses on Hodgkin's Lymphoma and Lymphoma. In particular, much of their work with Hodgkin's Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Philippe Armand, MD, PhD currently recruiting for clinical trials?
Yes, Philippe Armand, MD, PhD is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Philippe Armand, MD, PhD has studied deeply?
Yes, Philippe Armand, MD, PhD has studied treatments such as Brentuximab Vedotin, Nivolumab, Magrolimab.
What is the best way to schedule an appointment with Philippe Armand, MD, PhD?
Apply for one of the trials that Philippe Armand, MD, PhD is conducting.
What is the office address of Philippe Armand, MD, PhD?
The office of Philippe Armand, MD, PhD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top